These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
181 related articles for article (PubMed ID: 29718792)
1. A Younger Man With Localized Prostate Cancer Asks, "Which Type of Radiation Is Right for Me?". Bekelman JE J Clin Oncol; 2018 Jun; 36(18):1780-1784. PubMed ID: 29718792 [TBL] [Abstract][Full Text] [Related]
2. Prostate Cancer Radiotherapy: An Evolving Paradigm. Catton CN; Lukka H; Martin J J Clin Oncol; 2018 Oct; 36(29):2909-2913. PubMed ID: 30138084 [TBL] [Abstract][Full Text] [Related]
4. Optimization of Risk Stratification in Localized Prostate Cancer. Morgans AK J Clin Oncol; 2018 Feb; 36(6):528-532. PubMed ID: 29303624 [TBL] [Abstract][Full Text] [Related]
5. Salvage Radiotherapy for Biochemically Recurrent Prostate Cancer After Prostatectomy. Zumsteg ZS; Daskivich TJ; Sandler HM J Clin Oncol; 2016 Nov; 34(32):3829-3833. PubMed ID: 27573664 [TBL] [Abstract][Full Text] [Related]
6. To treat or not to treat, that is the question: the role of bone-targeted therapy in metastatic prostate cancer. Higano CS J Clin Oncol; 2014 Apr; 32(11):1107-11. PubMed ID: 24590651 [TBL] [Abstract][Full Text] [Related]
7. Concurrent Chemotherapy and Radiation Therapy for Inoperable Locally Advanced Non-Small-Cell Lung Cancer. Rosenzweig KE; Gomez JE J Clin Oncol; 2017 Jan; 35(1):6-10. PubMed ID: 27870565 [TBL] [Abstract][Full Text] [Related]
8. More advantages in detecting bone and soft tissue metastases from prostate cancer using Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003 [TBL] [Abstract][Full Text] [Related]
9. Decision Making in a Data-Poor Environment: Management of Brain Metastases From Testicular and Extragonadal Germ Cell Tumors. Gilligan T J Clin Oncol; 2016 Feb; 34(4):303-6. PubMed ID: 26668343 [TBL] [Abstract][Full Text] [Related]
10. Can Stereotactic Body Radiotherapy Effectively Treat Hepatocellular Carcinoma? Barry A; Knox JJ; Wei AC; Dawson LA J Clin Oncol; 2016 Feb; 34(5):404-8. PubMed ID: 26700118 [TBL] [Abstract][Full Text] [Related]
11. Duration of Anti-Programmed Death-1 Therapy in Advanced Melanoma: How Much of a Good Thing Is Enough? Khushalani NI J Clin Oncol; 2018 Jun; 36(17):1649-1653. PubMed ID: 29389234 [TBL] [Abstract][Full Text] [Related]
12. A comprehensive and novel predictive modeling technique using detailed pathology factors in men with localized prostate carcinoma. Potters L; Purrazzella R; Brustein S; Fearn P; Leibel SA; Kattan MW Cancer; 2002 Oct; 95(7):1451-6. PubMed ID: 12237913 [TBL] [Abstract][Full Text] [Related]
13. Feeding the Controversy: When Pelvic Irradiation Improves Outcomes in High-Risk and Very High-Risk Prostate Cancer. Jan I; Parikh RR J Clin Oncol; 2021 Apr; 39(11):1196-1202. PubMed ID: 33683923 [No Abstract] [Full Text] [Related]